{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:50:53Z","timestamp":1786996253564,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"am","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.revmed.2021.08.018","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T16:51:01Z","timestamp":1647622261000},"page":"212-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sarco\u00efdose cardiaque\u00a0: strat\u00e9gies diagnostiques et th\u00e9rapeutiques actuelles"],"prefix":"10.1016","volume":"43","author":[{"given":"A.C.","family":"Desbois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chapelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bergeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Badenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Redheuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.08.018_bib0380","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0385","doi-asserted-by":"crossref","first-page":"e0238391","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.revmed.2021.08.018_bib0390","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84\u00a0unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0395","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.118.034687","article-title":"Ventricular arrhythmias in cardiac sarcoidosis","volume":"138","author":"Okada","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0400","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.0954-6820.1983.tb03701.x","article-title":"ECG abnormalities in patients with sarcoidosis","volume":"213","author":"Thun\u00e9ll","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.revmed.2021.08.018_bib0405","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0410","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-8703(85)90524-1","article-title":"Echocardiographic evaluation of patients with systemic sarcoidosis","volume":"110","author":"Lewin","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.revmed.2021.08.018_bib0415","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(87)91095-6","article-title":"Non-invasive diagnosis of cardiac sarcoidosis","volume":"2","author":"Moiseyev","year":"1987","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.revmed.2021.08.018_bib0420","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10554-017-1233-9","article-title":"Myocardial contractile patterns predict future cardiac events in sarcoidosis","volume":"34","author":"Chen","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2016151289","article-title":"Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac MR imaging","volume":"280","author":"Lee","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2021.08.018_bib0430","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2214\/ajr.151.5.915","article-title":"MR imaging of myocardial sarcoidosis","volume":"151","author":"Riedy","year":"1988","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0435","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0440","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016\u00a0guideline on diagnosis and treatment of cardiac sarcoidosis\u00a0\u2013\u00a0digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.revmed.2021.08.018_bib0445","series-title":"Journal of Cardiovascular Magnetic Resonance","first-page":"37","article-title":"SCMR position paper (2020) on clinical indications for cardiovascular magnetic resonance","author":"Leiner","year":"2020"},{"key":"10.1016\/j.revmed.2021.08.018_bib0450","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","author":"Slart","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0455","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020\u00a0update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.revmed.2021.08.018_bib0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1532-429X-11-56","article-title":"T2\u00a0quantification for improved detection of myocardial edema","volume":"11","author":"Giri","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.revmed.2021.08.018_bib0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1\u00a0and T2\u00a0mapping in recognition of early cardiac involvement in systemic sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2021.08.018_bib0470","doi-asserted-by":"crossref","first-page":"O102","DOI":"10.1186\/1532-429X-18-S1-O102","article-title":"Assessment of left ventricular systolic and diastolic function in patients with sarcoidosis with and without cardiac involvement by magnetic resonance feature tracking at 1.5T: a follow up study","volume":"18","author":"Dabir","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.revmed.2021.08.018_bib0475","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2021.08.018_bib0480","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.revmed.2021.08.018_bib0485","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0490","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0495","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1\u00a0mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"10.1016\/j.revmed.2021.08.018_bib0500","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005022","article-title":"Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0505","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/a-0598-5099","article-title":"Diagnostic value of cardiac magnetic resonance strain analysis for detection of cardiac sarcoidosis","volume":"190","author":"Dabir","year":"2018","journal-title":"Rofo"},{"key":"10.1016\/j.revmed.2021.08.018_bib0510","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0515","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0520","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0525","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of heart\u00a0\u2013\u00a0clinicopathologic study of 35\u00a0necropsy patients (group-1) and review of 78\u00a0previously described necropsy patients (group 2)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0530","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis: cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0535","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0540","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18\u00a0FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0545","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1007\/s12350-019-01653-8","article-title":"Diagnostic performance of F18\u00a0FDG PET in cardiac sarcoidosis: are we getting closer to the truth?","volume":"27","author":"Jouni","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0550","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0555","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0560","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0565","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0570","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0575","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0585","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0590","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.revmed.2021.08.018_bib0595","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2020.07.034","article-title":"Lower left ventricular ejection fraction and higher serum angiotensin-converting enzyme activity are associated with histopathological diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis","volume":"321","author":"Komoriyama","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0600","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease\u00a0\u2013\u00a0A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2021.08.018_bib0605","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.revmed.2021.08.018_bib0610","first-page":"24","article-title":"The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008\u20132015: a nationwide population-based study","volume":"37","author":"Jeon","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2021.08.018_bib0615","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.revmed.2021.08.018_bib0620","article-title":"Magnetic resonance imaging as a predictor of survival free of life-threatening arrhythmias and transplantation in cardiac sarcoidosis","volume":"5","author":"Ekstr\u00f6m","year":"2016","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"10.1016\/j.revmed.2021.08.018_bib0625","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38\u00a0autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0630","first-page":"1165","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart Br Card Soc"},{"key":"10.1016\/j.revmed.2021.08.018_bib0635","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0640","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0645","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18\u00a0FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0650","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.revmed.2021.08.018_bib0655","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0660","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0665","first-page":"100342","article-title":"Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging","volume":"23","author":"Okada","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.revmed.2021.08.018_bib0670","first-page":"8","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.revmed.2021.08.018_bib0675","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis: effect of corticosteroid therapy","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0680","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jjcc.2013.07.007","article-title":"Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis","volume":"62","author":"Yodogawa","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0685","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2021.08.018_bib0690","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.revmed.2021.08.018_bib0695","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2021.08.018_bib0700","doi-asserted-by":"crossref","first-page":"e8846","DOI":"10.1097\/MD.0000000000008846","article-title":"Severe infections in sarcoidosis: incidence, predictors and long-term outcome in a cohort of 585\u00a0patients","volume":"96","author":"Dur\u00e9ault","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2021.08.018_bib0705","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.revmed.2021.08.018_bib0710","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis","volume":"124","author":"Harper","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0715","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132\u00a0patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2021.08.018_bib0720","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2021.08.018_bib0725","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2021.02.022","article-title":"Effectiveness and safety of infliximab in cardiac sarcoidosis","volume":"330","author":"Bakker","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0730","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0735","first-page":"9","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","author":"Segawa","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0740","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.revmed.2021.08.018_bib0745","first-page":"9","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.revmed.2021.08.018_bib0375","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321006500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321006500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:44:41Z","timestamp":1759337081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321006500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0248866321006500"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.08.018","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarco\u00efdose cardiaque\u00a0: strat\u00e9gies diagnostiques et th\u00e9rapeutiques actuelles","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}